Ftse Mib
33.876,90
0,42%
DAX
18.003,14
0,54%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.300,01
0,30%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ InMed Pharmaceuticals Inc (INM) InMed Pharmaceuticals Inc (INM) Notizie

InMed Pharmaceuticals Inc

INM
0,2595
-0,0044 (-1,67%)
Pre Mercato
Ultimo aggiornamento: 10:47:44
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202421:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202419:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202418:34EDGAR2Form 8-K - Current report
19/1/202420:33EDGAR2Form 8-K - Current report
16/1/202420:12EDGAR2Form 8-K - Current report
26/12/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202319:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202323:21EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06/12/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202320:50EDGAR2Form 8-K - Current report
14/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202323:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/11/202323:05EDGAR2Form S-1 - General form for registration of securities under..
02/11/202319:56EDGAR2Form 8-K - Current report
27/10/202322:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/10/202322:04EDGAR2Form DEF 14A - Other definitive proxy statements
24/10/202322:18EDGAR2Form 8-K - Current report
29/9/202323:18EDGAR2Form 8-K - Current report
29/9/202317:43EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/9/202317:30EDGAR2Form NT 10-K - Notification of inability to timely file Form..
25/9/202322:12EDGAR2Form 8-K - Current report
31/8/202323:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202322:26EDGAR2Form 8-K - Current report
20/7/202320:18EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 0,2639

La tua Cronologia

NASDAQ
INM
InMed Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network